Lexogen Launches miRVEL Discovery – Cutting-edge Small RNA-Seq Library Prep Kit for sRNA Discovery and Biomarker studies
21.05.2025, Vienna, Austria — Lexogen, a leader in RNA sequencing technologies, is excited to announce the launch of the miRVEL
21.05.2025, Vienna, Austria — Lexogen, a leader in RNA sequencing technologies, is excited to announce the launch of the miRVEL
RNA sequencing (RNA-Seq) is a powerful tool that can be applied at various stages of the drug discovery and development
RNA sequencing (RNA-Seq) has emerged as a cornerstone of cancer research and drug discovery, providing crucial insights for the development
Next generation sequencing (NGS) has significantly advanced omics research, enabling high-throughput sequencing of DNA and RNA at unprecedented scale and
Today’s scientific landscape for drug discovery is extremely fast-paced: new technologies emerge constantly accelerating discoveries. Time is of the essence
Vienna, Austria – 14.11.2024 – Lexogen, a pioneer in NGS Services, has launched a streamlined Blood RNA-Seq Service to expedite
Small molecule drugs, or low molecular weight compounds, are used as therapeutics to modulate physiological processes to treat or prevent
Collaboration to Enable Sequencing of Cellular Biopsies Zürich, Switzerland, and Vienna, Austria – October 15, 2024 Cytosurge AG, a leader
Traditional drug discovery often relies on single endpoint assays using visual markers, which can be challenging to quantify and limited
Vienna, Austria – 14. August 2024 Lexogen, a leader in RNA sequencing technologies, is thrilled to announce the launch of
In our previous Blog, we explored the importance and applications of RNA-Seq for plant transcriptomics and crop sciences. Even though
Gene expression studies are becoming an important tool for plant breeding and agricultural biotechnology. For example, RNA-Seq has been used
Lexogen GmbH
Campus Vienna Biocenter 5
1030 Vienna, Austria
Telephone:
+43 (0) 1 345 1212
Sales support:
+43 (0) 1 345 1212-42
Technical support:
+43 (0) 1 345 1212-41
Working hours: 9:00 – 17:00 (CET)
Fax: +43 (0) 1 345 1212-99
Email: info@lexogen.com
Company number: FN 297318 h
VAT number: ATU63622048
Lexogen, Inc.
51 Autumn Pond Park
Greenland, NH 03840, US
Telephone:
+1-603-431-4300 ext.0
+1-877-Lexogen
(+1-877-539-6436) ext. 0
Sales inquiries:
Northeast and Great Lakes:
+1 312-978-6413
California:
+1 415-726-4318
Rest of the Country:
+1 615-968-3325
Lexogen Newsletter
Subscribe to our mailing list to be among the first to get updates from us!
Copyright © 2026 Lexogen GmbH. All rights reserved | Impressum | Privacy Policy | Terms and Conditions | Whistleblowing
Please choose which cookies you'd like to use.
Required
These cookies are required to provide core site functionality. These can't be disabled.
Analytics
These cookies allow us to analyse usage of our site so we can improve its performance.
Marketing
These cookies are used by advertisers to show you ads relevant to your interests.

Product Short Description
PRICE

Product Short Description
PRICE

Product Short Description
PRICE